GSK Takes Cue From Schering Patient Assistance Program, Seeks Opinion From OIG
This article was originally published in The Pink Sheet Daily
HHS Office of Inspector General will decide whether GlaxoSmithKline can donate medicines to Part D-enrolled patients.
You may also be interested in...
A May 11 Senate Finance Committee meeting will discuss PAPs with pharma stakeholders.
The federal government is on the verge of ensuring that 90% of Medicare-eligible people receive prescription drug coverage, HHS Secretary Leavitt said.